Answer Details

Here are consistently top-tier West Coast options to consider (California, Oregon, Washington). They’re all NCI-designated Comprehensive Cancer Centers—a strong signal for advanced care and access to trials—and several appear near the top of recent national cancer rankings: California City of Hope (Duarte/LA area) — ranked top-5 nationally for cancer care in U.S. News 2024–25. cancer.gov +1 UCSF Helen Diller Family Comprehensive Cancer Center (San Francisco) — highest-ranking in Northern California for cancer care in the latest U.S. News cycle. cancer.gov +1 Stanford Cancer Institute (Palo Alto) — reported as a top-10 cancer hospital in the 2025 U.S. News rankings. cancer.gov +1 UCLA Jonsson Comprehensive Cancer Center (Los Angeles) — NCI Comprehensive center with broad subspecialty programs. cancer.gov Moores Cancer Center at UC San Diego (La Jolla) — NCI Comprehensive center; UC San Diego Health is top-ranked in its region. cancer.gov +1 USC Norris Comprehensive Cancer Center (Los Angeles) and UC Davis Comprehensive Cancer Center (Sacramento) — both NCI Comprehensive. cancer.gov Oregon OHSU Knight Cancer Institute (Portland) — NCI Comprehensive; major programs in precision oncology and early detection. cancer.gov Washington Fred Hutch/University of Washington/Seattle Children’s Cancer Consortium (Seattle) — NCI Comprehensive; internationally known for hematologic malignancies and transplants. cancer.gov How to choose among them NCI Comprehensive designation is a reliable first filter (all listed above have it). Use the NCI finder to explore each center’s programs and clinical trials. cancer.gov Recent rankings & news can help with tie-breakers (e.g., City of Hope top-5; Stanford top-10; UCSF regional leader). City of Hope +2 Stanford Medicine +2 Hospital safety: check your specific hospital’s current Leapfrog Safety Grade (Spring 2025 grades are live). Ziekenhuisveiligheidsgraad +1 If you tell me the cancer type (e.g., breast, lung, leukemia) and city preference, I can pare this down to the most relevant disease-specific programs and active clinical trials at 1-3 nearby centers.